Vetmedix: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Vetmedix
Largest movements
- Cash +€13,193
up €13,193 (+137.9%), from €9,569 to €22,762
mainly Net result for the year (+€12,197) and Depreciation (+€3,433)
- Tangible fixed assets -€3,433
down €3,433 (-35.6%), from €9,651 to €6,218
- Reserves +€12,197
up €12,197 (+878.1%), from €1,389 to €13,586
- Other debts -€4,624
down €4,624 (-40.2%), from €11,492 to €6,868
- Tax, wage and social debts +€3,359
up €3,359 (+104.8%), from €3,207 to €6,566
- Trade debts -€1,201
down €1,201 (-53.6%), from €2,240 to €1,039
- Gross operating margin +€16,042
up €16,042 (+508.0%), from €3,158 to €19,200
- Depreciation +€2,784
up €2,784 (+429.0%), from €649 to €3,433
- Taxes +€2,709
up €2,709 (+527.0%), from €514 to €3,223
- Other operating charges -€315
down €315 (-53.4%), from €591 to €275
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €19,328 | €29,060 | +€9,732 | +50.4% |
| Fixed assets | 21/28 | €9,651 | €6,218 | -€3,433 | -35.6% |
| Tangible fixed assets | 22/27 | €9,651 | €6,218 | -€3,433 | -35.6% |
| Furniture and vehicles | 24 | €9,651 | €6,218 | -€3,433 | -35.6% |
| Current assets | 29/58 | €9,677 | €22,842 | +€13,165 | +136.0% |
| Amounts receivable within one year | 40/41 | - | €80 | +€80 | |
| Trade receivables | 40 | - | €80 | +€80 | |
| Cash at bank and in hand | 54/58 | €9,569 | €22,762 | +€13,193 | +137.9% |
| Deferred charges and accrued income | 490/1 | €108 | - | -€108 | |
| Total equity and liabilities | 10/49 | €19,328 | €29,060 | +€9,732 | +50.4% |
| Equity | 10/15 | €2,389 | €14,586 | +€12,197 | +510.6% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €1,389 | €13,586 | +€12,197 | +878.1% |
| Distributable reserves | 133 | €1,389 | €13,586 | +€12,197 | +878.1% |
| Amounts payable | 17/49 | €16,939 | €14,474 | -€2,465 | -14.6% |
| Amounts payable within one year | 42/48 | €16,939 | €14,474 | -€2,465 | -14.6% |
| Trade debts | 44 | €2,240 | €1,039 | -€1,201 | -53.6% |
| Suppliers | 440/4 | €2,240 | €1,039 | -€1,201 | -53.6% |
| Taxes, remuneration and social security | 45 | €3,207 | €6,566 | +€3,359 | +104.8% |
| Taxes | 450/3 | €3,207 | €6,566 | +€3,359 | +104.8% |
| Other amounts payable | 47/48 | €11,492 | €6,868 | -€4,624 | -40.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €649 | €3,433 | +€2,784 | +429.0% |
| Other operating charges | 640/8 | €591 | €275 | -€315 | -53.4% |
| Gross operating margin | 9900 | €3,158 | €19,200 | +€16,042 | +508.0% |
| Operating profit (loss) | 9901 | €1,918 | €15,491 | +€13,573 | +707.6% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €15 | €70 | +€55 | +369.3% |
| Recurring financial charges | 65 | €15 | €70 | +€55 | +369.3% |
| Profit (loss) for the period before taxes | 9903 | €1,903 | €15,421 | +€13,517 | +710.3% |
| Income taxes | 67/77 | €514 | €3,223 | +€2,709 | +527.0% |
| Profit (loss) for the period | 9904 | €1,389 | €12,197 | +€10,808 | +778.1% |
| Profit (loss) for the period to be appropriated | 9905 | €1,389 | €12,197 | +€10,808 | +778.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.